Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for Arachidonate 5- Lipoxygenase
Most Correlated Studies
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
- Broad Connectivity Map (CMAP 2.0) compound database
- Drug target sets for approved compounds
Most Relevant Literature
- Structure and ligand based design for identification of highly potent molecules against 5-LOX.
- ALOX5-mediated ferroptosis acts as a distinct cell death pathway upon oxidative stress in Huntington…
- Role of ALOX5 in non-small cell lung cancer: A potential therapeutic target associated with immune c…
- ALOX5 promotes autophagy-dependent ferroptosis by activating the AMPK/mTOR pathway in melanoma.
- Association between a single nucleotide polymorphism of the ALOX5 gene and susceptibility to multisy…
Most Relevant Clinical Trials
- Study of the Arachidonate 5-Lipoxygenase Enzyme in Affecting the Risk for Coronary Heart Disease
- The Role of Arachidonic Acid Metabolites, From Patients With Metabolic Syndrome
- Fish Oil to Prevent Asthma Exacerbations in Patients With ALOX5 Polymorphisms
- Safety of Zileuton (Zyflo) in Combination With Imatinib Mesylate (Gleevec) in CML.
- Heart & Health Study
